Today all chip designs begin as lines of code. The code is written at a high level, hiding much of the complexity from the designer, and then synthesized into a low-level description for layout and ...
Stop at any booth at the Embedded Systems Conference and you'll see a demo of the latest and greatest tool for accelerating the time to market for your latest project. Just like Moore's Law has ...
TipRanks on MSN
HeartBeam (NASDAQ: BEAT) secures FDA 510(k) clearance for 12-lead ECG synthesis software following successful appeal
Austin, Texas, United States, December 10th, 2025, FinanceWire HeartBeam (NASDAQ: BEAT), a medical technology company focused ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it ...
As long as humans write software by hand, errors will remain inevitable. “Automatically synthesizing systems that are correct ...
Unlike any single-lead or 6-lead consumer device, HeartBeam’s patented cable-free technology captures the heart’s electrical signals in three non-coplanar dimensions and synthesizes them into a ...
The Peptide-ExplorerLT ™ is designed for scientists who need to optimize and explore linear peptide synthesis. The product is a high-spec flow chemistry system that uses continuous flow. The product ...
The Roland Cloud is looking brighter with their latest addition announced today, a series of Model Expansions beginning with the JX-8P Model Expansion. Upcoming releases will include SH-101, JUNO-106, ...
Secures FDA 510(K) Clearance For 12-Lead ECG Synthesis Software Following Successful Appeal. HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback